1. Home
  2. CRC vs RLAY Comparison

CRC vs RLAY Comparison

Compare CRC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Resources Corporation

CRC

California Resources Corporation

HOLD

Current Price

$53.96

Market Cap

4.8B

Sector

Energy

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$20.09

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRC
RLAY
Founded
2014
2015
Country
United States
United States
Employees
2500
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CRC
RLAY
Price
$53.96
$20.09
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
$72.57
$19.50
AVG Volume (30 Days)
740.0K
2.0M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
$12.37
N/A
Revenue Next Year
N/A
$324.03
P/E Ratio
$13.50
N/A
Revenue Growth
N/A
53.44
52 Week Low
$43.25
$3.24
52 Week High
$71.98
$20.79

Technical Indicators

Market Signals
Indicator
CRC
RLAY
Relative Strength Index (RSI) 54.51 61.66
Support Level $50.27 $18.02
Resistance Level $54.86 $20.59
Average True Range (ATR) 1.75 1.00
MACD 0.34 -0.01
Stochastic Oscillator 72.84 79.67

Price Performance

Historical Comparison
CRC
RLAY

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: